With more states reporting record numbers of new infections of coronavirus disease 2019 (COVID-19), the United States has surpassed 3 million confirmed cases; the Trump administration has notified the United Nations that it will be withdrawing from the World Health Organization (WHO); a new injectable given to patients every 2 months can protect against HIV better than the commonly used daily pill.
With more states reporting record numbers of new infections of coronavirus disease 2019 (COVID-19), the United States has surpassed 3 million confirmed cases, according to Reuters. California, Hawaii, Idaho, Missouri, Montana, Oklahoma, and Texas all easily surpassed previous daily records for new cases, and Texas and California each had more than 10,000. The rise in cases has led to more Americans seeking COVID-19 screenings, and HHS has added short-term testing sites in Florida, Louisiana, and Texas.
The Trump administration has notified the United Nations that it will be withdrawing from the World Health Organization (WHO) over its response to the COVID-19 pandemic. The Associated Press reported that health officials and critics of the administration blasted the move, saying it would cost the United States influence globally. The withdrawal would not take effect until next year and if former Vice President Joe Biden, the presumptive Democratic presidential nominee, wins in the November election, he could rescind the decision.
A new injectable given to patients every 2 months can protect against HIV better than the commonly used daily pill, according to researchers. The high price for daily HIV prevention pills like Truvada and Descovy has highlighted the need for other prevention options, The New York Times reported. The trial evaluating the long-acting injectable, cabotegravir, was stopped in May after an interim analysis showed it was highly effective. The shot taken every 2 months was 66% more effective than Truvada.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen